Copyright
©The Author(s) 2020.
World J Clin Cases. Aug 6, 2020; 8(15): 3142-3155
Published online Aug 6, 2020. doi: 10.12998/wjcc.v8.i15.3142
Published online Aug 6, 2020. doi: 10.12998/wjcc.v8.i15.3142
Table 2 Joensuu criteria for gastrointestinal stromal tumor risk assessment
| Risk category | Tumor size (cm) | Mitotic index (per 50 HPF) | Primary tumor site |
| Very low | < 2 | ≤ 5 | Any |
| Low | 2.1-5 | ≤ 5 | Any |
| Intermediate | 2.1–5 | > 5 | Gastric |
| < 5 | 6–10 | Any | |
| 5.1-10 | ≤ 5 | Gastric | |
| High | Any | Any | Tumor rupture |
| > 10 | Any | Any | |
| Any | > 10 | Any | |
| > 5 | > 5 | Any | |
| 2.1–5 | > 5 | Non-gastric | |
| 5.1-10 | ≤ 5 | Non-gastric |
- Citation: Ahmed M. Recent advances in the management of gastrointestinal stromal tumor. World J Clin Cases 2020; 8(15): 3142-3155
- URL: https://www.wjgnet.com/2307-8960/full/v8/i15/3142.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i15.3142